Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) Return on Sales (2023 - 2025)

Historic Return on Sales for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to 12.92%.

  • Zenas BioPharma's Return on Sales changed N/A to 12.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.92%, marking a year-over-year change of. This contributed to the annual value of 32.27% for FY2024, which is 315300.0% down from last year.
  • Latest data reveals that Zenas BioPharma reported Return on Sales of 12.92% as of Q3 2025.
  • Over the past 5 years, Zenas BioPharma's Return on Sales peaked at 0.71% during Q3 2023, and registered a low of 12.92% during Q3 2025.
  • In the last 3 years, Zenas BioPharma's Return on Sales had a median value of 7.33% in 2024 and averaged 6.67%.
  • The largest annual percentage gain for Zenas BioPharma's Return on Sales in the last 5 years was -109600bps (2025), contrasted with its biggest fall of -109600bps (2025).
  • Quarter analysis of 3 years shows Zenas BioPharma's Return on Sales stood at 0.71% in 2023, then plummeted by -1687bps to 11.31% in 2024, then fell by -14bps to 12.92% in 2025.
  • Its Return on Sales was 12.92% in Q3 2025, compared to 12.06% in Q2 2025 and 3.36% in Q1 2025.